Transcatheter Pulmonary Valve Replacement: A Review of Current Valve Technologies

Neil D Patel; Daniel S Levi; John P Cheatham; Shakeel A Qureshi; Shabana Shahanavaz; Evan M Zahn

doi:10.1016/j.jscai.2022.100452

Transcatheter Pulmonary Valve Replacement: A Review of Current Valve Technologies

J Soc Cardiovasc Angiogr Interv. 2022 Sep 16;1(6):100452. doi: 10.1016/j.jscai.2022.100452. eCollection 2022 Nov-Dec.

Authors

Neil D Patel¹, Daniel S Levi², John P Cheatham³, Shakeel A Qureshi⁴, Shabana Shahanavaz⁵, Evan M Zahn⁶

Affiliations

¹ Children's Hospital Los Angeles, Los Angeles, California.
² Mattel Children's Hospital at The University of California, Los Angeles, Los Angeles, California.
³ Nationwide Children's Hospital, Columbus, Ohio.
⁴ Evelina London Children's Hospital, London, United Kingdom.
⁵ Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.
⁶ Cedars-Sinai Medical Center, Los Angeles, California.

Abstract

Transcatheter pulmonary valve replacement was first performed by Dr Philip Bonhoeffer, who implanted a Medtronic Melody valve in a human in 2000. Over the past 2 decades, there have been many advances in transcatheter pulmonary valve technology. This includes the use of the SAPIEN transcatheter heart valve in the pulmonary position, modifications and refinements to valve implantation procedures, and development of self-expanding valves and prestents to treat large diameter native or patched right ventricular outflow tracts. This article reviews the current transcatheter pulmonary valve technologies with a focus on valve design, screening process, implant procedure, and clinical outcomes.

Keywords: pulmonary valve replacement; tetralogy of Fallot; transcatheter.

Publication types

Review